v.baptista
TL2 · Nairobi
Contributes reviews on supplier material. Based in Nairobi.
Joined 18 September 2025 · last posted 3d · groups: newcomer-guides
82 posts, newest first. Showing up to 150.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #92 · Compounds › Retatrutide · 25 Jul 2026 · 19 likes Post #91 is right about the mechanism and I think understates the practical bit. Summarising the retatrutide discussion thread so far, since it is long and the answer…
-
Research-use-only status: what it means legally and practically Replied, post #81 · Compounds › Other compounds · 25 Jul 2026 · 3 likes The honest answer on research-use-only status is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they…
-
Here for the analytics and not much else Replied, post #89 · Lounge › Introductions · 25 Jul 2026 · 18 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community. Flagging that the sources on…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #73 · Outcomes › Body composition · 24 Jul 2026 · 0 likes What I can speak to on ultrasound and skinfolds is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
When a dose reduction is the correct response to a side effect Replied, post #41 · Practice › Dosing & titration · 21 Jul 2026 · 16 likes Post #40 is right about the mechanism and I think understates the practical bit. Writing down the date, the dose and the site each week takes fifteen seconds and is the…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #62 · Evidence › Journal club · 14 Jul 2026 · 2 likes On SUSTAIN 6, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #74 · Outcomes › Progress reports · 12 Jul 2026 · 0 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding. Posting it because the silence on this was starting…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #30 · Start Here › Welcome · 11 Jul 2026 · 1 like The arithmetic on Reading order is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Search filters: what is missing Replied, post #78 · Meta › Site feedback · 8 Jul 2026 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #57 · Start Here › Welcome · 3 Jul 2026 · 6 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Coming back to: Light exposure: how much protection is proportionate? Replied, post #9 · Practice › Storage & stability · 1 Jul 2026 · 0 likes Picking up post #6: that is the part I would want checked first. Reconstituted material carried in a bag for a day is a temperature excursion even in a cool climate.…
-
Research-use-only status: what it means legally and practically Replied, post #64 · Compounds › Other compounds · 25 Jun 2026 · 12 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Tracking a shortage from primary sources rather than rumour Replied, post #52 · Access › Shortages · 15 Jun 2026 · 7 likes Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out. Not the whole picture, but the part of it I…
-
Racemisation and why it is invisible to a mass measurement Replied, post #112 · Analytics › Impurities & related substances · 14 Jun 2026 · 13 likes Post #110 describes the usual case. This is about the unusual one. Relative response factors mean impurities are not detected in proportion to how much of them is…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #68 · Safety › Contraindications · 10 Jun 2026 · 1 like Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #13 · Analytics › HPLC & UHPLC · 7 Jun 2026 · 17 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #3 · Start Here › Welcome · 1 Jun 2026 · 0 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #17 · Evidence › Journal club · 2 May 2026 · 5 likes Something worth flagging about semaglutide in MASH: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #117 · Analytics › Mass spectrometry · 21 Apr 2026 · 15 likes Whatever the answer on Adducts turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Step therapy requirements and how to satisfy them Replied, post #3 · Access › Insurance & coverage · 18 Apr 2026 · 0 likes Where I have landed on step therapy requirements, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Sample handling between despatch and injection Replied, post #10 · Analytics › Method validation · 31 Mar 2026 · 9 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #20 · Evidence › Journal club · 31 Mar 2026 · 4 likes Indirect comparison was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #50 · Compounds › Tirzepatide · 19 Mar 2026 · 18 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #66 · Clinical › Bloodwork · 18 Mar 2026 · 22 likes Confirming post #63 from a second method, which matters more than confirming it from a second person. Time of day: some biomarkers vary across the day. Cortisol in the…
-
Grapefruit: why this class is not the class that cares Replied, post #27 · Practice › Interactions · 10 Mar 2026 · 1 like I read post #25 twice before replying, because I had assumed the opposite. Oral contraceptive absorption has been studied specifically for some compounds in this class…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #18 · Practice › Storage & stability · 7 Mar 2026 · 20 likes Where I part company with post #14, and it is a narrow parting. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #7 · Sourcing › Independent verification · 7 Mar 2026 · 0 likes A supplier that supplies a supplementary certificate for a lot released a year ago has demonstrated that its records exist and are retrievable. That is a real property.…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #30 · Practice › Reconstitution · 3 Mar 2026 · 3 likes Building on post #29 rather than restating it. Choosing a concentration sits at the boundary between what this community can usefully discuss and what it cannot, and I…
-
Reading an interaction checker output critically Replied, post #126 · Practice › Interactions · 21 Feb 2026 · 26 likes This follows post #125 rather than contradicting it. Trying to state the reading an interaction checker output position in a way that someone who disagrees would…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #5 · Compounds › Repair & healing peptides · 1 Feb 2026 · 0 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Trifluoroacetate content and its consequences Replied, post #7 · Analytics › Impurities & related substances · 22 Jan 2026 · 2 likes Incomplete deprotection leaves a protecting group attached, raising the mass substantially and usually pushing retention much later. A late-eluting peak on a peptide…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #56 · Sourcing › Red flags · 19 Jan 2026 · 20 likes Distinguishing three things in the supplier discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #46 · Meta › Site feedback · 17 Jan 2026 · 2 likes Offering a way to settle topic list rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
A parcel stationary at a customs facility for nine days Replied, post #19 · Sourcing › Logistics · 11 Jan 2026 · 5 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #136 · Compounds › Oral incretins · 8 Jan 2026 · 0 likes Post #135 is the version of this I will quote in future. One addition. Orforglipron is a small molecule rather than a peptide, which changes almost everything about how…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #38 · Practice › Side effects · 6 Jan 2026 · 13 likes I read post #34 twice before replying, because I had assumed the opposite. Discontinuation for adverse effects in the published trials was not rare at the higher doses.…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #64 · Compounds › Oral incretins · 3 Jan 2026 · 24 likes Confirming post #61 from a second method, which matters more than confirming it from a second person. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an…
-
Dizziness on standing and the electrolyte explanation Replied, post #3 · Practice › Side effects · 25 Dec 2025 · 16 likes Post #2 is right about the mechanism and I think understates the practical bit. I would be cautious about generalising from the dizziness on standing example above. It…
-
Documentation that appears only after payment Replied, post #108 · Sourcing › Red flags · 16 Dec 2025 · 2 likes Everything in post #106 holds. The case it does not cover is the one I have. Second-hand on documentation, so weight it accordingly — someone whose method I trust told…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #40 · Sourcing › Independent verification · 12 Dec 2025 · 1 like Having read the whole interpreting a result thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #84 · Analytics › COA interpretation · 6 Dec 2025 · 0 likes Taking post #83 at face value and following it one step further. The distinction between release testing and characterisation is one industrial documents make and…
-
Search filters: what is missing Replied, post #7 · Meta › Site feedback · 3 Dec 2025 · 7 likes No notes. Posting so the count is not one.
-
Tracking a preprint to publication: a worked example Started this topic · Evidence › Preprints · 27 Nov 2025 · 9 likes Tracking a preprint to publication: a worked example Writing it up because I had to work it out twice and would rather nobody else did. A preprint question rather than…
-
Second pass at: Programming during a large energy deficit Replied, post #90 · Nutrition & Training › Resistance training · 21 Nov 2025 · 13 likes Post #89 describes the usual case. This is about the unusual one. Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to…
-
Realistic expectations for strength while losing weight quickly Replied, post #28 · Nutrition & Training › Resistance training · 14 Oct 2025 · 0 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Cost per delivered dose, which is the number that matters Replied, post #14 · Access › Pricing · 13 Oct 2025 · 8 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #16 · Data & Tools › Calculators · 4 Oct 2025 · 19 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with. I would rather be precise about…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #17 · Documentation › Doc review · 29 Sep 2025 · 1 like Confirming post #16 from a second method, which matters more than confirming it from a second person. Two people in this thread mean different things by evidence digest…
-
How to read a forest plot, properly, from scratch Replied, post #33 · Evidence › Trials · 27 Sep 2025 · 30 likes That is a fair summary of where the discussion has got to.
-
Payment method and the leverage it gives you, ranked Replied, post #36 · Sourcing › Payments · 19 Sep 2025 · 2 likes Confirming the total before paying rather than after is obvious and is skipped constantly, particularly where shipping is added late.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #99 · Compounds › Oral incretins · 11 Sep 2025 · 26 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #117 · Evidence › Journal club · 26 Aug 2025 · 0 likes This follows post #116 rather than contradicting it. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that…
-
When a preprint is the best available evidence and we say so Replied, post #85 · Evidence › Preprints · 22 Aug 2025 · 33 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #86 · Compounds › Cagrilintide & amylin analogues · 20 Aug 2025 · 1 like Post #82 put the caveat in the right place and I want to underline it. The documentation on cagrisema phase 2 paper is better than this thread and I say that as someone…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #6 · Meta › Announcements · 11 Aug 2025 · 0 likes Posting my Scheduled maintenance numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Travel coolers and how long they really hold Replied, post #33 · Devices › Cold chain · 3 Aug 2025 · 24 likes Do not judge cold-chain performance from a single delivery in either direction. It is a distribution and one sample from it is one sample. I would put a moderate…
-
Revisiting: German, French and Dutch differences, compared Replied, post #52 · Regional › European Union · 31 Jul 2025 · 9 likes Post #49 is right about the mechanism and I think understates the practical bit. Correcting a stale claim here is more valuable than adding a new one, because the stale…
-
[2026 update] Reverting an edit that had no revision note Replied, post #6 · Meta › Wiki maintenance · 26 Jul 2025 · 3 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict. This is the sort of thing the wiki should…
-
A field-by-field walk through a certificate of analysis Replied, post #127 · Analytics › COA interpretation · 18 Jul 2025 · 18 likes Where I part company with post #123, and it is a narrow parting. Field-by-field walk through a certificate is worth one more sentence than it usually gets, and the…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #6 · Wellbeing › Mental health · 12 Jul 2025 · 0 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. I am confident about…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Started this topic · Analytics › HPLC & UHPLC · 21 Jun 2025 · 45 likes Area percent versus weight percent: the confusion that causes most arguments — what changed since Writing it up because I had to work it out twice and would rather…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #42 · Evidence › Journal club · 17 Jun 2025 · 0 likes Post #41 is the version of this I will quote in future. One addition. The most common failure mode is spending fifty minutes on the effect size and ten on the…
-
A report I filed that turned out to be wrong, and the correction Replied, post #99 · Sourcing › Vendor reports · 12 Jun 2025 · 0 likes Building on post #98 rather than restating it. The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and…
-
Insulin combinations and hypoglycaemia risk Started this topic · Practice › Interactions · 4 Jun 2025 · 50 likes On the subject in the title: Insulin combinations and hypoglycaemia risk Working notes rather than a conclusion. I was wrong about insulin combinations and…
-
Reading a supplier's product description as a marketing document Replied, post #27 · Compounds › Other compounds · 28 May 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Pregnancy as an absolute contraindication Replied, post #39 · Safety › Contraindications · 18 May 2025 · 0 likes Taking post #37 at face value and following it one step further. Where a condition appears as a warning rather than a contraindication, the decision is a clinical one…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #61 · Sourcing › Independent verification · 7 May 2025 · 29 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. I have deliberately not rounded…
-
Albumin binding and how it produces a long half-life Replied, post #30 · Pharmacology › Pharmacokinetics · 29 Apr 2025 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #29 · Practice › Interactions · 28 Mar 2025 · 14 likes Post #27 is the version of this I will quote in future. One addition. Food interactions: most interactions are absorption interactions. Some medications absorb better…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #35 · Evidence › Journal club · 10 Mar 2025 · 8 likes Post #31 and I disagree about the size of the effect, not about the direction. If you are new and reading this thread for the answer to SURMOUNT-OSA: the answer is…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #14 · Sourcing › Vendor reports · 10 Mar 2025 · 4 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #105 · Compounds › Semaglutide · 12 Feb 2025 · 9 likes Worth separating two things that post #101 runs together. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #16 · Compounds › Tirzepatide · 5 Feb 2025 · 0 likes The titration schedule has more steps than semaglutide's, which reflects the finer gradation used in the clinical programme rather than a pharmacological requirement…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #36 · Analytics › COA interpretation · 21 Jan 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #74 · Compounds › Tirzepatide · 7 Dec 2024 · 0 likes Answering the question post #70 raises rather than the one it answers. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
Washout with a one-week half-life: the arithmetic Replied, post #12 · Research Methods › N-of-1 designs · 24 Nov 2024 · 0 likes One caution on washout: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Two sessions a week versus four: what the evidence supports Replied, post #9 · Nutrition & Training › Resistance training · 20 Nov 2024 · 4 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop. I have no interest in any…
-
Fixed versus detachable needles: the trade-offs Replied, post #8 · Devices › Syringes & needles · 17 Nov 2024 · 19 likes Reading back through the fixed versus detachable needles threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Second pass at: Reimbursement variation across member states Replied, post #16 · Regional › European Union · 5 Oct 2024 · 6 likes Anyone quoting an eligibility threshold should cite the national document, because thresholds differ between states and have changed within them.
-
The mass-error checker and its intended scope Replied, post #163 · Data & Tools › Calculators · 29 Jul 2024 · 0 likes Marking my uncertainty on mass-error checker explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #115 · Compounds › Retatrutide · 24 Jul 2024 · 30 likes Careful with the language on Retatrutide dose escalation. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Mean kinetic temperature explained without the mathematics Replied, post #2 · Practice › Storage & stability · 24 Jul 2024 · 18 likes The opening post put the caveat in the right place and I want to underline it. Light protection is easy and cheap. The original carton exists for a reason and a vial…